<DOC>
	<DOCNO>NCT00462020</DOCNO>
	<brief_summary>The objective study scientifically evaluate two different management strategy perforate appendicitis . The hypothesis early discharge oral antibiotic therapy may result dramatic decrease medical care expense patient . The primary outcome variable two strategy abscess rate .</brief_summary>
	<brief_title>Intravenous Versus Intravenous/Oral Antibiotics Perforated Appendicitis</brief_title>
	<detailed_description>This single institution , prospective , randomized clinical trial involve patient present hospital perforate appendicitis . This definitive study . Power calculation base abscess rate previous prospective , randomize study finish . Our current rate 18 % , one-fifth patient . A double rate 36 % would place one third patient risk would unacceptable . Using delta 0.18 alpha 0.05 power 0.8 , sample size 74 patient arm . Therefore anticipate enrol 150 . Subjects child undergo laparoscopic appendectomy part routine care . Perforation define identifiable hole appendix stool abdomen . The control group receive current standard care : ceftriaxone 50mg/kg day ( maximum dose = 2 gram ) metronidazole 30mg/kg day ( maximum dose = 1 gram ) day dose . The length antibiotic therapy minimum 5 day . At time , afebrile least 24 hour , white blood cell ( WBC ) count obtain , within normal limit , antibiotic discontinue patient discharge . If WBC elevate , receive another 2 day recheck , still elevate , receive another 3 day CT obtain . If , 5 day therapy , patient remain febrile , therapy continue afebrile WBC check perform . This current standard management . The experimental group receive combination antibiotic hospital . When patient tolerate regular diet , oral pain medication afebrile 12 hour , discharge oral antibiotic complete course 7 day . The home antibiotic regimen ampicillin/clavulanic acid ( Augmentin® ) . Augmentin® dose 40mg/kg twice day . They ask bring pill containers clinic quantify medication compliance . Given purpose study comparison oral antibiotic intravenous antibiotic , allergy one medication consider exclusion criterion . In case patient treat alternative offer spectrum coverage , include study .</detailed_description>
	<mesh_term>Appendicitis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Ampicillin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Identifiable hole appendix stool abdomen time appendectomy Known immune deficiency Abscess identify preop image Another condition affect surgical decision making recovery ( e.g . hemophilia , severe cardiac respiratory comorbidities ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>appendicitis , perforation , abscess , treatment</keyword>
</DOC>